Utah Medical Products UTMD Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's operating lease right-of-use asset amortization?
- Utah Medical Products (UTMD) reported operating lease right-of-use asset amortization of $15K in Q1 2026.
- How has Utah Medical Products's operating lease right-of-use asset amortization changed year-over-year?
- Utah Medical Products's operating lease right-of-use asset amortization increased by 25.0% year-over-year, from $12K to $15K.
- What is the long-term trend for Utah Medical Products's operating lease right-of-use asset amortization?
- Over 3 years (2022 to 2025), Utah Medical Products's operating lease right-of-use asset amortization has grown at a 1.9% compound annual growth rate (CAGR), from $53K to $56K.